top of page
Search

NEW #Alzheimer’s Drug Controversy Continues ‣

  • Kai
  • Oct 21, 2021
  • 1 min read

In four papers, #researchers and journalists take on aducanumab's controversial #FDAapproval


Their mission? Analyze what went wrong



ree

 
 
 

Comments

Couldn’t Load Comments
It looks like there was a technical problem. Try reconnecting or refreshing the page.
bottom of page